Article Text
Letters
A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C
Statistics from Altmetric.com
Footnotes
-
Contributors All authors made substantial intellectual contributions to the conception of the work, analysis and interpretation of the data, and drafting and revising the manuscript.
-
Funding None.
-
Competing interests None.
-
Patient consent Obtained.
-
Ethics approval The Ethics Committee of Taichung Veterans General Hospital.
-
Provenance and peer review Not commissioned; externally peer reviewed.